Cargando…
Resistance to Second-Line Anti-TB Drugs in Cambodia: A Phenotypic and Genetic Study
BACKGROUND: Due to the emergence of Mycobacterium tuberculosis (M.tb) clinical isolates resistant to most potent first-line drugs (FLD), second-line drugs (SLD) are being prescribed more frequently. We explore the genetic characteristics and molecular mechanisms of M.tb isolates phenotypically resis...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982564/ https://www.ncbi.nlm.nih.gov/pubmed/33762833 http://dx.doi.org/10.2147/IDR.S289907 |
_version_ | 1783667746104410112 |
---|---|
author | Cheng, Sokleaph Hide, Mallorie Pheng, Sok Heng Kerléguer, Alexandra Delvallez, Gauthier Sam, Sophan Mao, Tan Eang Nguyen, Thi Van Anh Bañuls, Anne-Laure |
author_facet | Cheng, Sokleaph Hide, Mallorie Pheng, Sok Heng Kerléguer, Alexandra Delvallez, Gauthier Sam, Sophan Mao, Tan Eang Nguyen, Thi Van Anh Bañuls, Anne-Laure |
author_sort | Cheng, Sokleaph |
collection | PubMed |
description | BACKGROUND: Due to the emergence of Mycobacterium tuberculosis (M.tb) clinical isolates resistant to most potent first-line drugs (FLD), second-line drugs (SLD) are being prescribed more frequently. We explore the genetic characteristics and molecular mechanisms of M.tb isolates phenotypically resistant to SLD, including pre-extensively drug-resistant (pre-XDR) and extensively drug-resistant (XDR) isolates. METHODS: Drug-resistant (DR) M.tb isolates collected from 2012 to 2017 were tested using sequencing and phenotypic drug susceptibility testing. Genotypes were determined to explore their links with SLD resistance patterns. RESULTS: Of the 272 DR M.tb isolates, 6 non-multidrug resistant (non-MDR) isolates were fluoroquinolones (FQ)-resistant, 3 were XDR and 16 were pre-XDR (14 resistant to FQ and 2 to second-line injectable drugs). The most frequent mutations in FQ-resistant and second-line injectable drugs resistant isolates were gyrA D94G (15/23) and rrs a1401g (3/5), respectively. Seventy-five percent of pre-XDR isolates and 100% of XDR isolates harbored mutations conferring resistance to pyrazinamide. All XDR isolates belonged to the Beijing genotype, of which one, named XDR+, was resistant to all drugs tested. One cluster including pre-XDR and XDR isolates was observed. CONCLUSION: This is the first description of SLD resistance in Cambodia. The data suggest that the proportion of XDR and pre-XDR isolates remains low but is on the rise compared to previous reports. The characterization of the XDR+ isolate in a patient who refused treatment underlines the risk of transmission in the population. In addition, genotypic results show, as expected, that the Beijing family is the main involved in pre-XDR and XDR isolates and that the spread of the Beijing pre-XDR strain is capable of evolving into XDR strain. This study strongly indicates the need for rapid interventions in terms of diagnostic and treatment to prevent the spread of the pre-XDR and XDR strains and the emergence of more resistant ones. |
format | Online Article Text |
id | pubmed-7982564 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-79825642021-03-23 Resistance to Second-Line Anti-TB Drugs in Cambodia: A Phenotypic and Genetic Study Cheng, Sokleaph Hide, Mallorie Pheng, Sok Heng Kerléguer, Alexandra Delvallez, Gauthier Sam, Sophan Mao, Tan Eang Nguyen, Thi Van Anh Bañuls, Anne-Laure Infect Drug Resist Original Research BACKGROUND: Due to the emergence of Mycobacterium tuberculosis (M.tb) clinical isolates resistant to most potent first-line drugs (FLD), second-line drugs (SLD) are being prescribed more frequently. We explore the genetic characteristics and molecular mechanisms of M.tb isolates phenotypically resistant to SLD, including pre-extensively drug-resistant (pre-XDR) and extensively drug-resistant (XDR) isolates. METHODS: Drug-resistant (DR) M.tb isolates collected from 2012 to 2017 were tested using sequencing and phenotypic drug susceptibility testing. Genotypes were determined to explore their links with SLD resistance patterns. RESULTS: Of the 272 DR M.tb isolates, 6 non-multidrug resistant (non-MDR) isolates were fluoroquinolones (FQ)-resistant, 3 were XDR and 16 were pre-XDR (14 resistant to FQ and 2 to second-line injectable drugs). The most frequent mutations in FQ-resistant and second-line injectable drugs resistant isolates were gyrA D94G (15/23) and rrs a1401g (3/5), respectively. Seventy-five percent of pre-XDR isolates and 100% of XDR isolates harbored mutations conferring resistance to pyrazinamide. All XDR isolates belonged to the Beijing genotype, of which one, named XDR+, was resistant to all drugs tested. One cluster including pre-XDR and XDR isolates was observed. CONCLUSION: This is the first description of SLD resistance in Cambodia. The data suggest that the proportion of XDR and pre-XDR isolates remains low but is on the rise compared to previous reports. The characterization of the XDR+ isolate in a patient who refused treatment underlines the risk of transmission in the population. In addition, genotypic results show, as expected, that the Beijing family is the main involved in pre-XDR and XDR isolates and that the spread of the Beijing pre-XDR strain is capable of evolving into XDR strain. This study strongly indicates the need for rapid interventions in terms of diagnostic and treatment to prevent the spread of the pre-XDR and XDR strains and the emergence of more resistant ones. Dove 2021-03-17 /pmc/articles/PMC7982564/ /pubmed/33762833 http://dx.doi.org/10.2147/IDR.S289907 Text en © 2021 Cheng et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Cheng, Sokleaph Hide, Mallorie Pheng, Sok Heng Kerléguer, Alexandra Delvallez, Gauthier Sam, Sophan Mao, Tan Eang Nguyen, Thi Van Anh Bañuls, Anne-Laure Resistance to Second-Line Anti-TB Drugs in Cambodia: A Phenotypic and Genetic Study |
title | Resistance to Second-Line Anti-TB Drugs in Cambodia: A Phenotypic and Genetic Study |
title_full | Resistance to Second-Line Anti-TB Drugs in Cambodia: A Phenotypic and Genetic Study |
title_fullStr | Resistance to Second-Line Anti-TB Drugs in Cambodia: A Phenotypic and Genetic Study |
title_full_unstemmed | Resistance to Second-Line Anti-TB Drugs in Cambodia: A Phenotypic and Genetic Study |
title_short | Resistance to Second-Line Anti-TB Drugs in Cambodia: A Phenotypic and Genetic Study |
title_sort | resistance to second-line anti-tb drugs in cambodia: a phenotypic and genetic study |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982564/ https://www.ncbi.nlm.nih.gov/pubmed/33762833 http://dx.doi.org/10.2147/IDR.S289907 |
work_keys_str_mv | AT chengsokleaph resistancetosecondlineantitbdrugsincambodiaaphenotypicandgeneticstudy AT hidemallorie resistancetosecondlineantitbdrugsincambodiaaphenotypicandgeneticstudy AT phengsokheng resistancetosecondlineantitbdrugsincambodiaaphenotypicandgeneticstudy AT kerlegueralexandra resistancetosecondlineantitbdrugsincambodiaaphenotypicandgeneticstudy AT delvallezgauthier resistancetosecondlineantitbdrugsincambodiaaphenotypicandgeneticstudy AT samsophan resistancetosecondlineantitbdrugsincambodiaaphenotypicandgeneticstudy AT maotaneang resistancetosecondlineantitbdrugsincambodiaaphenotypicandgeneticstudy AT nguyenthivananh resistancetosecondlineantitbdrugsincambodiaaphenotypicandgeneticstudy AT banulsannelaure resistancetosecondlineantitbdrugsincambodiaaphenotypicandgeneticstudy |